You are here

Resize Text
See all clinical trials

A Randomized, Double-Blind, Placebo-Controlled Clinical Study To Assess The Safety And Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy

A phase 2b, randomized, double-blind, placebo-controlled clinical study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) versus placebo in subjects with and without pulmonary hypertension associated with pulmonary fibrosis on long term oxygen therapy. 

Clinical Trial Information

Protocol
TIRB#: 25059, WIRB#: 20172181
Phase
2
Conditions
Pulmonary Hypertension
Investigator
Jeffrey Stewart, MD
Coordinator
Dee Fehrle

Visit clinicaltrials.gov for full clinical trial description.

Contact

For more information about this trial or to inquire about eligibility, email breathe@temple.edu

 

Full Title

A Randomized, Double-Blind, Placebo-Controlled Clinical Study To Assess The Safety And Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2)